The diagnostics industry saves lives every day and makes a significant contribution to optimal therapeutic success. Diagnostics and pharmaceuticals are increasingly cooperating in the development of new active substances, stratification of patients, and the safety and efficacy of therapies. The market for biomarkers is growing significantly. The diagnostics companies that can best adapt to the changing conditions will be the winners of this change: away from classic pay-per-result/pay-per-test business models towards value-driven diagnostics. We support you in meeting these changes in the best possible way with the help of optimized processes and customer value orientation on the way to significantly increased productivity and profitability.
Business model transformation from classic diagnostics to companion.
A significant reduction in time to market for new products was to be achieved at our customer. As a result, we were able to increase the success rate and shorten the lead time.
Central labs receive thousands of samples per hour which need to linked to the sending physician, the patient and the payer prior to processing. Physical and administrative processing is complicated despite the latest automation techniques.